Philip Weighner
Internal Medicine · Grand Rapids, MINPI 1710945480
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 344 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,174 and has fallen 98.6% since, to $31 in 2023. Among internal medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 344 payments — averaging $15.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$820
- Boehringer Ingelheim$617
- AstraZeneca$533
- AbbVie$435
- Pfizer$398
- Amarin Pharma, Inc.$336
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,15995%
- Education$2485%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 46 | $820 |
| Boehringer Ingelheim | 39 | $617 |
| AstraZeneca(2 entities) | 32 | $533 |
| AbbVie | 29 | $435 |
| Pfizer | 28 | $398 |
| Amarin Pharma, Inc. | 30 | $336 |
| Lilly USA, LLC | 26 | $314 |
| Johnson & Johnson | 20 | $253 |
| Astellas Pharma US Inc | 7 | $222 |
| Novartis | 11 | $176 |
| Amgen | 9 | $168 |
| Bayer | 11 | $160 |
| Merck | 8 | $145 |
| Sanofi-aventis U.S. LLC | 8 | $140 |
| E.r. Squibb & Sons, L.L.C. | 8 | $118 |
| Biohaven Pharmaceuticals, Inc. | 3 | $82 |
| Xeris Pharmaceuticals, Inc. | 3 | $67 |
| Daiichi Sankyo Inc. | 3 | $59 |
| GSK | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Sanofi Pasteur Inc. | 2 | $35 |
| Abbott | 2 | $32 |
| Mylan Specialty L.p. | 2 | $30 |
| Grifols USA, LLC | 1 | $24 |
| Gilead | 2 | $24 |
| Philips North America LLC | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
| Nabriva Therapeutics, PLC | 1 | $12 |
| Radius Health, Inc. | 1 | $12 |
How this compares
$5,408 in reported general payments places this provider in the 90th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Grand Rapids
- Robert SelfeGrand Rapids$238K
- Celia EganGrand Rapids$54K
- Jeremy GentileGrand Rapids$44K
- Terry SmithAnn Arbor$2.3M
- Michael ValituttoKalamazoo$1.8M
- Ulka VaishampayanAnn Arbor$996K
- Tina AbrahamPontiac$834K
- Steven KatzmanLivonia$715K
- Adam FormanSouthfield$453K
- Saroj NeupaneDetroit$373K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.